Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice

Bone

Volumn 45, Issue 1, 2009, Pages 61-67

  Kalak, Robert ^a   Zhou, Hong ^a   Street, Janine ^a   Day, Robert E ^b   Modzelewski, James R K ^a   Spies, Cornelia M ^a,c   Liu, Peter Y ^a   Li, Gang ^d   Dunstan, Colin R ^a,e   Seibel, Markus J ^a,f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e Biomedical Engineering   (Australia)

^f Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Bone; Glucocorticoids; Hydroxysteroid dehydrogenase; Mouse; Osteoblasts

Indexed keywords

GLUCOCORTICOID; SEX HORMONE;

ANIMAL CELL; ARTICLE; BIOMECHANICS; BONE DEVELOPMENT; BONE GROWTH; BONE STRENGTH; BONE STRUCTURE; COMPRESSIVE STRENGTH; CONTROLLED STUDY; CORTICAL BONE; FEMALE; LUMBAR VERTEBRA; MALE; MOUSE; NONHUMAN; OSTEOBLAST; PERIOSTEUM; SEXUAL MATURATION; SIGNAL TRANSDUCTION; TIBIA; TRABECULAR BONE; TRANSGENE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; AGING; ANIMALS; BIOMECHANICS; BODY WEIGHT; BONE AND BONES; FEMALE; GLUCOCORTICOIDS; MALE; MICE; MICE, TRANSGENIC; ORGAN SIZE; OSTEOBLASTS; RATS; SEXUAL MATURATION; SIGNAL TRANSDUCTION; SPINE; TIBIA;

EID: 67349094534     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.03.673     Document Type: Article

References (26)

1. Adinoff A.D., and Hollister J.R. Steroid-induced fractures and bone loss in patients with asthma. N. Engl. J. Med. 309 (1983) 265-268
2. Cushing H. The basophil adenomas of the pituitary and their clinical manifestations. Bull. Johns Hopkins Hosp. 50 (1932) 137-195
3. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., and Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23 (1999) 99-103
4. Seibel M.J. Markers of bone turnover in transplantation osteopathy. Clin. Lab. 42 (1996) 927-937
5. Shane E., Rivas M., McMahon D.J., Staron R.B., Silverberg S.J., Seibel M.J., Mancini D., Michler R.E., Aaronson K., Addesso V., and Lo S.H. Bone loss and turnover after cardiac transplantation. J. Clin. Endocrinol. Metab. 82 (1997) 1497-1506
6. Shane E., Rivas M., Staron R.B., Silverberg S.J., Seibel M.J., Kuiper J., Mancini D., Addesso V., Michler R.E., and Factor-Litvak P. Fracture after cardiac transplantation: a prospective longitudinal study. J. Clin. Endocrinol. Metab. 81 (1996) 1740-1746
7. Dempster D.W., Arlot M.A., and Meunier P.J. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif. Tissue Int. 35 (1983) 410-417
8. Aubin J.E. Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation. J. Cell. Biochem. 72 (1999) 396-410
9. Bellows C.G., Aubin J.E., and Heersche J.N. Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121 (1987) 1985-1992
10. Sher L.B., Woitge H.W., Adams D.J., Gronowicz G.A., Krozowski Z., Harrison J.R., and Kream B.E. Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology 145 (2004) 922-929
11. Sher L.B., Harrison J.R., Adams D.J., and Kream B.E. Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Calcif. Tissue Int. 79 (2006) 118-125
12. Zhou H., Mak W., Kalak R., Street J., Fong-Yee C., Zheng Y., Dunstan C.R., and Seibel M.J. Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice. Development 136 (2009) 427-436
13. Zhou H., Mak W., Zheng Y., Dunstan C.R., and Seibel M.J. Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J. Biol. Chem. 283 (2008) 1936-1945
14. Woitge H., Harrison J., Ivkosic A., Krozowski Z., and Kream B. Cloning and in vitro characterization of alpha 1(I)-collagen 11 beta-hydroxysteroid dehydrogenase type 2 transgenes as models for osteoblast-selective inactivation of natural glucocorticoids. Endocrinology 142 (2001) 1341-1348
15. Hahn M., Vogel M., Pompesius-Kempa M., and Delling G. Trabecular bone pattern factor-a new parameter for simple quantification of bone microarchitecture. Bone 13 (1992) 327-330
16. Furr R.M. A contrast analysis approach to change. Educ. Res. Eval. 14 (2008) 335-362
17. Kalajzic I., Kalajzic Z., Kaliterna M., Gronowicz G., Clark S.H., Lichtler A.C., and Rowe D. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J. Bone Miner. Res. 17 (2002) 15-25
18. Mikuni-Takagaki Y. Mechanical responses and signal transduction pathways in stretched osteocytes. J. Bone Miner. Metab. 17 (1999) 57-60
19. Skerry T.M. The response of bone to mechanical loading and disuse: fundamental principles and influences on osteoblast/osteocyte homeostasis. Arch. Biochem. Biophys. 473 (2008) 117-123
20. Leclerc N., Luppen C.A., Ho V.V., Nagpal S., Hacia J.G., Smith E., and Frenkel B. Gene expression profiling of glucocorticoid-inhibited osteoblasts. J. Mol. Endocrinol. 33 (2004) 175-193
21. Chia R., Achilli F., Festing M.F., and Fisher E.M. The origins and uses of mouse outbred stocks. Nat. Genet. 37 (2005) 1181-1186
22. Hernandez J.L., Garces C.M., Sumillera M., Fernandez-Aldasoro E.V., Garcia-Ibarbia C., Ortiz-Gomez J.A., Arozamena J., Alonso M.A., and Riancho J.A. Aromatase expression in osteoarthritic and osteoporotic bone. Arthritis Rheum. 58 (2008) 1696-1700
23. Enjuanes A., Garcia-Giralt N., Supervia A., Nogues X., Ruiz-Gaspa S., Bustamante M., Mellibovsky L., Grinberg D., Balcells S., and Diez-Perez A. Functional analysis of the I.3, I.6, pII and I.4 promoters of CYP19 (aromatase) gene in human osteoblasts and their role in vitamin D and dexamethasone stimulation. Eur. J. Endocrinol. 153 (2005) 981-988
24. Watanabe M., Noda M., and Nakajin S. Aromatase expression in a human osteoblastic cell line increases in response to prostaglandin E(2) in a dexamethasone-dependent fashion. Steroids 72 (2007) 686-692
25. O'Brien C.A., Jia D., Plotkin L.I., Bellido T., Powers C.C., Stewart S.A., Manolagas S.C., and Weinstein R.S. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145 (2004) 1835-1841
26. Dacic S., Kalajzic I., Visnjic D., Lichtler A.C., and Rowe D.W. Col1a1-driven transgenic markers of osteoblast lineage progression. J. Bone Miner. Res. 16 (2001) 1228-1236